Full Text Journal Articles by
Author Kiyoshi Takeda

Advertisement

Find full text journal articles






An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia.

Natsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, Ryu Okumura, Hiroko Nakajima, Hikaru Minagawa, Soyoko Morimoto, Fumihiro Fujiki, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Kiyoshi Takeda, Akihiro Tsuboi, Keiichi Ozono,

Wilms' tumor 1 (WT1) is a promising tumor-associated antigen for cancer immunotherapy. We developed an oral protein vaccine platform composed of WT1-anchored, genetically engineered Bifidobacterium longum (B. longum) and conducted an in vivo study in mice to examine its anticancer activity. Mice were orally treated with phosphate-buffered saline, wild-type B. ... Read more >>

Cancer Immunol Immunother (Cancer immunology, immunotherapy : CII)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.

Yuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, Hiroya Oki, Yoshimi Noda, Yuichi Adachi, Takayuki Niitsu, Shota Okamoto, Kentaro Tanaka, Kiyoharu Fukushima, Saori Amiya, Reina Hara, Eri Oguro-Igashira, Takanori Matsuki, Haruhiko Hirata, Yoshito Takeda, Hiroshi Kida, Atsushi Kumanogoh, Shota Nakamura, Kiyoshi Takeda,

<h4>Background</h4>The impact of SARS-CoV-2 infection on the gut fungal (mycobiota) and bacterial (microbiota) communities has been elucidated individually. This study analyzed both gut mycobiota and microbiota and their correlation in the COVID-19 patients with severe and mild conditions and follow-up to monitor their alterations after recovery.<h4>Methods</h4>We analyzed the gut mycobiota ... Read more >>

BMC Infect Dis (BMC infectious diseases)
[2022, 22(1):572]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.5325 s